Aug 21, 2026
1:10
For every 10 shares held, investors received 1. The price per share adjusted from $0.29 to $2.94.
The split itself did not change the total investment value.
Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) operates in the Pharmaceuticals: other industry.
Scinai Immunotherapeutics Ltd. company overviewScinai Immunotherapeutics Ltd.'s most recent stock split was on August 21, 2026. It was a 1-for-10 reverse split, so shareholders received 1 share for every 10 they held.
Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) has split its stock 3 times: a 1-for-10 reverse split on November 25, 2022, a 1-for-10 reverse split on May 21, 2024, and a 1-for-10 reverse split on August 21, 2026.
Scinai Immunotherapeutics Ltd. has split its stock 3 times. This history records 3 reverse splits between November 25, 2022 and August 21, 2026.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Scinai Immunotherapeutics Ltd.'s 1-for-10 reverse split on August 21, 2026, every 10 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Scinai Immunotherapeutics Ltd. has not announced a new split in our records. Its most recent split was on August 21, 2026, less than a year ago. Companies announce splits in advance, and any new NASDAQ:SCNI split will appear on this page.
Already premium?